BRAIN CANCER

This study tested a drug called VAL-083 combined with standard radiation for people newly diagnosed with a fast-growing brain cancer (glioblastoma) that has a specific genetic marker (unmethylated MGMT). The goal was to find a safe dose and see if the combination helps control th…

This study tested a new MRI contrast agent called RVP-001 in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions without using gadolinium, a metal that can build up in the bo…

This study tested a new imaging technique that combines a special tracer called [18F]PARPi with PET and MRI scans to get clearer pictures of brain tumors. Five adults with new or suspected returning brain tumors took part. The goal was to see how well this method shows tumor acti…

This study tested whether a program called eSNAP, combined with a caregiver navigator, could reduce anxiety, depression, and burden in family caregivers of people with brain cancer. About 296 caregivers and patients took part. The program involved assessing the caregiver's social…

This study tested a counseling program called CALM (Managing Cancer and Living Meaningfully) for people with malignant brain cancer. The goal was to see if it's practical and helpful for reducing distress like depression and anxiety about death. 60 participants were offered eithe…

This study tested a new program to help brain cancer survivors with thinking, memory, and daily life. 27 survivors and their carers took part. The program focused on real-life skills and included both patients and their carers.

This study tested whether a simple walking program, using fitness trackers, helps cancer patients tolerate their daily chemotherapy and radiation treatments without missing doses. 166 adults with various cancers (brain, head/neck, lung, GI, or cervical) who were scheduled for cur…

This study enrolled 1214 people with brain or spinal cord tumors to collect medical information, blood, urine, spinal fluid, and tumor tissue samples. The goal was to better understand these tumors and identify new areas for research. Participants also received guidance on managi…

This study analyzed tumor and blood samples from 84 patients with brain cancer, meningioma, or sarcoma to find biomarkers that predict how well proton beam therapy works. The goal is to identify genetic or immune markers linked to tumor shrinkage six months after treatment. This …